FDA-Approved CAR-T Therapies
In addition to the novel CAR-T therapies offered through our clinical trials program, our care team can provide our patients two FDA-approved therapies:
Kymriah for acute lymphoblastic leukemia or non-Hodgkin lymphoma
Yescarta for non-Hodgkin lymphoma
Please contact Catherine Cheng, email@example.com, 919-445-4208, to learn more about either of these therapies or to refer a patient.